Bone marrow core biopsy in 508 consecutive patients with chronic myeloid leukemia: Assessment of potential value

Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring

(2016) Elias Jabbour et al.   AMERICAN JOURNAL OF HEMATOLOGY

Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characterization of 7 cases

(2016) Le Le Aye et al.   Annals of Diagnostic Pathology

BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features

(2016) Nina Rosa Neuendorff et al.   ANNALS OF HEMATOLOGY

Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

(2016) W. Wang et al.   BLOOD

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

(2016) D. A. Arber et al.   BLOOD

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial

(2016) Jorge E. Cortes et al.   JOURNAL OF CLINICAL ONCOLOGY

Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy

(2016) Z Chen et al.   LEUKEMIA

Clinical significance of acquired loss of the X chromosome in bone marrow

(2016) Zhenya Tang et al.   LEUKEMIA RESEARCH

A review of the European LeukemiaNet recommendations for the management of CML

(2015) Michele Baccarani et al.   ANNALS OF HEMATOLOGY

Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors

(2015) W. Wang et al.   BLOOD

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

(2013) M. Baccarani et al.   BLOOD

Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV

(2013) Rüdiger Hehlmann et al.   JOURNAL OF CLINICAL ONCOLOGY